Oxford Nanopore supplies a PromethION 2 sequencer to Manchester University
- Manchester University NHS Foundation Trust
- North West
- Below threshold - without competition
- 30 September 2026 to 30 August 2029
Manchester University NHS Foundation Trust bought an Oxford Nanopore PromethION 2 Integrated Sequencing Unit. The trust wanted the nanopore sequencer for work on circulating tumour DNA (ctDNA).
The trust awarded the £51,613 contract directly to Oxford Nanopore Technologies in September 2026, with no competition. It runs for 35 months, to August 2029.
Contract ends August 2029
- What
- Genomic sequencing platforms and consumables
- Supplier
- Oxford Nanopore Technologies
- Value
- £51,613
- How it was bought
- Below threshold - without competition
- Dates and next
- Sep 2026 to Aug 2029